Synergistic Bifurcation Treatment System

Publication ID: 24-11857442_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Bifurcation Treatment System,” Published Technical Disclosure No. 24-11857442_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857442_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,442.

Summary of the Inventive Concept

The present inventive concept integrates advanced technologies, such as AI, IoT, blockchain, and nanomaterials, with the patented stenting and treatment of bifurcated vessels to create a more powerful and effective system for treating bifurcations.

Background and Problem Solved

The original patent addresses the limitations of traditional stenting methods for treating bifurcated vessels. However, the new inventive concept recognizes that the original patent's approach can be further improved by incorporating synergistic combinations of distinct technologies. The new concept solves the problem of limited stent placement accuracy, inadequate real-time monitoring, and inefficient data transmission in traditional bifurcation treatment systems.

Detailed Description of the Inventive Concept

The Synergistic Bifurcation Treatment System comprises a stent delivery catheter integrated with an AI-powered imaging module for real-time visualization of vessel anatomy and optimal stent placement. The system also features a blockchain-secured, IoT-enabled stent delivery system that tracks and verifies stent deployment, ensuring secure data transmission to a healthcare network. Additionally, the system incorporates a biodegradable stent infused with micro-sensors for real-time monitoring of vessel health and stent performance, along with a data analytics module for predicting stent failure and optimizing treatment outcomes. The system can also be integrated with a robotic-assisted stent delivery catheter and a machine learning algorithm for predicting optimal stent placement and minimizing procedural complications. Furthermore, the system can utilize a nanomaterial-based stent coated with a therapeutic agent, which is designed to release the agent in a controlled manner, and the system tracks and verifies agent delivery and efficacy.

Novelty and Inventive Step

The new inventive concept's novelty lies in the synergistic combination of advanced technologies, such as AI, IoT, blockchain, and nanomaterials, with the patented stenting and treatment of bifurcated vessels. The inventive step is the integration of these distinct technologies to create a more powerful and effective system for treating bifurcations, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Bifurcation Treatment System could include the use of different AI algorithms, varying IoT connectivity protocols, or alternative blockchain architectures. Variations could also include the integration of additional sensors or imaging modalities, such as ultrasound or optical coherence tomography, to further enhance the system's accuracy and effectiveness.

Potential Commercial Applications and Market

The Synergistic Bifurcation Treatment System has significant commercial potential in the medical device industry, particularly in the fields of interventional cardiology and vascular surgery. The system's ability to improve stent placement accuracy, reduce procedural complications, and enhance patient outcomes could lead to widespread adoption in hospitals and healthcare networks worldwide.

CPC Classifications

SectionClassGroup
A A61 A61F2/954
A A61 A61B90/39
A A61 A61F2/852
A A61 A61F2/856
A A61 A61F2/958
A A61 A61B2090/3966

Original Patent Information

Patent NumberUS 11,857,442
TitleSystem and methods for treating a bifurcation
Assignee(s)Advanced Bifurcation Systems Inc.